Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-30 @ 10:56 AM
Study NCT ID:
NCT00113360
Status:
COMPLETED
Last Update Posted:
2025-05-01
First Post:
2005-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-07
First Submit QC Date:
None
Study First Post Date:
2005-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-08-12
Results First Submit QC Date:
None
Results First Post Date:
2010-12-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-24
Last Update Post Date:
2025-05-01
Last Update Post Date Type:
ACTUAL